Dr. Sonia Anna Penaroza, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 1401 Medical Pkwy Ste 407, Cedar Park, TX 78613 Phone: 512-879-1461 |
Kimberly Sue Throckmorton, AUD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 910 E Whitestone Blvd, Cedar Park, TX 78613 Phone: 512-260-6135 |
Dr. Hyuna Bae, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2001 Windy Ter Ste F, Cedar Park, TX 78613 Phone: 512-430-5215 |
Candace Johnson, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1603 Medical Pkwy Ste 200, Cedar Park, TX 78613 Phone: 512-260-2665 |
Sears Hearing Aid Centers Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11200 Lakeline Mall Dr, Cedar Park, TX 78613 Phone: 512-257-8122 |
Dclc Enterprises, Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 601 Whitestone Blvd, Suite 712, Cedar Park, TX 78613 Phone: 512-260-2665 Fax: 512-260-2668 |
Elizabeth Sperino, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1603 Medical Pkwy Ste 200, Cedar Park, TX 78613 Phone: 512-260-2665 Fax: 512-260-2668 |
Anyplace Audiology And Hearing Aids Audiologist Medicare: Medicare Enrolled Practice Location: 2001 Windy Ter Ste F, Cedar Park, TX 78613 Phone: 512-270-5215 |
Emily Thompson, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 1603 Medical Pkwy Ste 200, Cedar Park, TX 78613 Phone: 512-260-2665 |
News Archive
Results from a University of Pittsburgh study demonstrate that intensity-modulated radiation therapy (IMRT) for head and neck cancer can be uniformly delivered in a large health care system of academic and community cancer centers through a centralized planning and treatment process.
The Philippines has reported a sharp increase in confirmed cases of the coronavirus disease (COVID-19), with the death toll now at 33. The country has also seen the fall of front liner health workers amid the coronavirus fight, with three doctors succumbing to the infection.
Merck Serono S.A. has announced that Phase III data on safinamide, a new agent in Phase III development for the treatment of Parkinson's disease symptoms, were presented by Professor Fabrizio Stocchi at the American Academy of Neurology 59th Annual Meeting in Boston, Massachusetts, USA.
In a remarkable and unprecedented collaboration NEWMEDS (Novel Methods leading to NeW MEdications in Depression and Schizophrenia) have pooled resources to bring together data of 23,401 anonymized patients from 67 trials on 11 compounds in over 25 countries to form the single largest database of clinical trial data ever amassed in psychiatric research.
› Verified 6 days ago